Kenneth Lawless

Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.

The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada.

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.

SHI Consulting, Inc. operates as a business management consultancy. The company was founded by Borys Chabursky and is headquartered in Toronto, Canada.

Scientus Pharma, Inc. provides biopharmaceutical products extracted from the cannabis plant. The private company is based in Whitby, Canada.

HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada.

The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016.

SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA.

Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA.

The Ottawa Hospital Research Institute is based in Ottawa, CA. The Canadian company provides world-class care with compassionate people.

Part of ICON plc, Pharmaceutical Research Associates International, Inc. is a Canadian company that provides clinical trials management and product development planning services. The company is based in Victoria, Canada. The company was founded by Kenneth Edward Newport, Erich Mohr. Pharmaceutical Research Associates International was acquired by PRA Health Sciences, Inc., part of ICON plc from July 01, 2021.

MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation.

Armour Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development of a new class of anti-hormone therapeutics for the treatment of reproductive tissue-based cancers. The company was founded by Josh Silvertown in 2009 and is headquartered in Toronto, Canada.

Prime Trials Ltd. operates clinical laboratories. The company is headquartered in Vancouver, Canada.

Trycycle Data Systems, Inc. engages in the provision of predictive software solution designed to help clinicians who treat and manage patients with addiction, substance use, mental health, depression, and post-traumatic stress disorder. It specializes on the insights based on movement, location, and sentiment. The company was founded by John Macbeth and Ken House in 2012 and is headquartered in Ottawa, Canada.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

Part of SinoPac Financial Holdings Co., Ltd., SinoPac Securities Corp. is a Taiwanese company that provides online brokerage and consultancy services. The company is based in Taipei, Taiwan. The company was founded in 1988. The CEO is Wei Yuan Chiang.